Global Spinal Muscular Atrophy Treatment Market Growth (Status and Outlook) 2023-2029

February 2023 | 64 pages | ID: GC876F0BDE89EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Spinal muscular atrophy is a genetic disorder characterized by weakness and wasting (atrophy ) in muscles used for movement (skeletal muscles). It is caused by a loss of specialized nerve cells, called motor neurons that control muscle movement. It's not currently possible to cure spinal muscular atrophy (SMA), but research is ongoing to find new treatments.

LPI (LP Information)' newest research report, the “Spinal Muscular Atrophy Treatment Industry Forecast” looks at past sales and reviews total world Spinal Muscular Atrophy Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Spinal Muscular Atrophy Treatment sales for 2023 through 2029. With Spinal Muscular Atrophy Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spinal Muscular Atrophy Treatment industry.

This Insight Report provides a comprehensive analysis of the global Spinal Muscular Atrophy Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Spinal Muscular Atrophy Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Spinal Muscular Atrophy Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spinal Muscular Atrophy Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spinal Muscular Atrophy Treatment.

The global Spinal Muscular Atrophy Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Spinal Muscular Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Spinal Muscular Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Spinal Muscular Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Spinal Muscular Atrophy Treatment players cover Biogen, Roche and Avexis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Muscular Atrophy Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Oral
• Intrathecal

Segmentation by application

• SMA Type 1
• SMA Type 2
• SMA Type 3
• SMA Type 4

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Biogen
• Roche
• Avexis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Spinal Muscular Atrophy Treatment Market Size 2018-2029
  2.1.2 Spinal Muscular Atrophy Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Spinal Muscular Atrophy Treatment Segment by Type
  2.2.1 Oral
  2.2.2 Intrathecal
2.3 Spinal Muscular Atrophy Treatment Market Size by Type
  2.3.1 Spinal Muscular Atrophy Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2018-2023)
2.4 Spinal Muscular Atrophy Treatment Segment by Application
  2.4.1 SMA Type
  2.4.2 SMA Type
  2.4.3 SMA Type
  2.4.4 SMA Type
2.5 Spinal Muscular Atrophy Treatment Market Size by Application
  2.5.1 Spinal Muscular Atrophy Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2018-2023)

3 SPINAL MUSCULAR ATROPHY TREATMENT MARKET SIZE BY PLAYER

3.1 Spinal Muscular Atrophy Treatment Market Size Market Share by Players
  3.1.1 Global Spinal Muscular Atrophy Treatment Revenue by Players (2018-2023)
  3.1.2 Global Spinal Muscular Atrophy Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Muscular Atrophy Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SPINAL MUSCULAR ATROPHY TREATMENT BY REGIONS

4.1 Spinal Muscular Atrophy Treatment Market Size by Regions (2018-2023)
4.2 Americas Spinal Muscular Atrophy Treatment Market Size Growth (2018-2023)
4.3 APAC Spinal Muscular Atrophy Treatment Market Size Growth (2018-2023)
4.4 Europe Spinal Muscular Atrophy Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023)
5.2 Americas Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023)
5.3 Americas Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Spinal Muscular Atrophy Treatment Market Size by Region (2018-2023)
6.2 APAC Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023)
6.3 APAC Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Spinal Muscular Atrophy Treatment by Country (2018-2023)
7.2 Europe Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023)
7.3 Europe Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Spinal Muscular Atrophy Treatment by Region (2018-2023)
8.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SPINAL MUSCULAR ATROPHY TREATMENT MARKET FORECAST

10.1 Global Spinal Muscular Atrophy Treatment Forecast by Regions (2024-2029)
  10.1.1 Global Spinal Muscular Atrophy Treatment Forecast by Regions (2024-2029)
  10.1.2 Americas Spinal Muscular Atrophy Treatment Forecast
  10.1.3 APAC Spinal Muscular Atrophy Treatment Forecast
  10.1.4 Europe Spinal Muscular Atrophy Treatment Forecast
  10.1.5 Middle East & Africa Spinal Muscular Atrophy Treatment Forecast
10.2 Americas Spinal Muscular Atrophy Treatment Forecast by Country (2024-2029)
  10.2.1 United States Spinal Muscular Atrophy Treatment Market Forecast
  10.2.2 Canada Spinal Muscular Atrophy Treatment Market Forecast
  10.2.3 Mexico Spinal Muscular Atrophy Treatment Market Forecast
  10.2.4 Brazil Spinal Muscular Atrophy Treatment Market Forecast
10.3 APAC Spinal Muscular Atrophy Treatment Forecast by Region (2024-2029)
  10.3.1 China Spinal Muscular Atrophy Treatment Market Forecast
  10.3.2 Japan Spinal Muscular Atrophy Treatment Market Forecast
  10.3.3 Korea Spinal Muscular Atrophy Treatment Market Forecast
  10.3.4 Southeast Asia Spinal Muscular Atrophy Treatment Market Forecast
  10.3.5 India Spinal Muscular Atrophy Treatment Market Forecast
  10.3.6 Australia Spinal Muscular Atrophy Treatment Market Forecast
10.4 Europe Spinal Muscular Atrophy Treatment Forecast by Country (2024-2029)
  10.4.1 Germany Spinal Muscular Atrophy Treatment Market Forecast
  10.4.2 France Spinal Muscular Atrophy Treatment Market Forecast
  10.4.3 UK Spinal Muscular Atrophy Treatment Market Forecast
  10.4.4 Italy Spinal Muscular Atrophy Treatment Market Forecast
  10.4.5 Russia Spinal Muscular Atrophy Treatment Market Forecast
10.5 Middle East & Africa Spinal Muscular Atrophy Treatment Forecast by Region (2024-2029)
  10.5.1 Egypt Spinal Muscular Atrophy Treatment Market Forecast
  10.5.2 South Africa Spinal Muscular Atrophy Treatment Market Forecast
  10.5.3 Israel Spinal Muscular Atrophy Treatment Market Forecast
  10.5.4 Turkey Spinal Muscular Atrophy Treatment Market Forecast
  10.5.5 GCC Countries Spinal Muscular Atrophy Treatment Market Forecast
10.6 Global Spinal Muscular Atrophy Treatment Forecast by Type (2024-2029)
10.7 Global Spinal Muscular Atrophy Treatment Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Biogen
  11.1.1 Biogen Company Information
  11.1.2 Biogen Spinal Muscular Atrophy Treatment Product Offered
  11.1.3 Biogen Spinal Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Biogen Main Business Overview
  11.1.5 Biogen Latest Developments
11.2 Roche
  11.2.1 Roche Company Information
  11.2.2 Roche Spinal Muscular Atrophy Treatment Product Offered
  11.2.3 Roche Spinal Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Roche Main Business Overview
  11.2.5 Roche Latest Developments
11.3 Avexis
  11.3.1 Avexis Company Information
  11.3.2 Avexis Spinal Muscular Atrophy Treatment Product Offered
  11.3.3 Avexis Spinal Muscular Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Avexis Main Business Overview
  11.3.5 Avexis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Spinal Muscular Atrophy Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Intrathecal
Table 4. Spinal Muscular Atrophy Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 7. Spinal Muscular Atrophy Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 10. Global Spinal Muscular Atrophy Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Player (2018-2023)
Table 12. Spinal Muscular Atrophy Treatment Key Players Head office and Products Offered
Table 13. Spinal Muscular Atrophy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Spinal Muscular Atrophy Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Spinal Muscular Atrophy Treatment Market Size Market Share by Regions (2018-2023)
Table 18. Global Spinal Muscular Atrophy Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Spinal Muscular Atrophy Treatment Market Size Market Share by Country (2018-2023)
Table 22. Americas Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 24. Americas Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 26. APAC Spinal Muscular Atrophy Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Spinal Muscular Atrophy Treatment Market Size Market Share by Region (2018-2023)
Table 28. APAC Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 30. APAC Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 32. Europe Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Spinal Muscular Atrophy Treatment Market Size Market Share by Country (2018-2023)
Table 34. Europe Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 36. Europe Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Spinal Muscular Atrophy Treatment
Table 45. Key Market Challenges & Risks of Spinal Muscular Atrophy Treatment
Table 46. Key Industry Trends of Spinal Muscular Atrophy Treatment
Table 47. Global Spinal Muscular Atrophy Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Spinal Muscular Atrophy Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Spinal Muscular Atrophy Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Spinal Muscular Atrophy Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Spinal Muscular Atrophy Treatment Area Served and Its Competitors
Table 52. Biogen Spinal Muscular Atrophy Treatment Product Offered
Table 53. Biogen Spinal Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Roche Details, Company Type, Spinal Muscular Atrophy Treatment Area Served and Its Competitors
Table 57. Roche Spinal Muscular Atrophy Treatment Product Offered
Table 58. Roche Main Business
Table 59. Roche Spinal Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Roche Latest Developments
Table 61. Avexis Details, Company Type, Spinal Muscular Atrophy Treatment Area Served and Its Competitors
Table 62. Avexis Spinal Muscular Atrophy Treatment Product Offered
Table 63. Avexis Main Business
Table 64. Avexis Spinal Muscular Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Avexis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Spinal Muscular Atrophy Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Spinal Muscular Atrophy Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Spinal Muscular Atrophy Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Spinal Muscular Atrophy Treatment Sales Market Share by Country/Region (2022)
Figure 8. Spinal Muscular Atrophy Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Spinal Muscular Atrophy Treatment Market Size Market Share by Type in 2022
Figure 10. Spinal Muscular Atrophy Treatment in SMA Type 1
Figure 11. Global Spinal Muscular Atrophy Treatment Market: SMA Type 1 (2018-2023) & ($ Millions)
Figure 12. Spinal Muscular Atrophy Treatment in SMA Type 2
Figure 13. Global Spinal Muscular Atrophy Treatment Market: SMA Type 2 (2018-2023) & ($ Millions)
Figure 14. Spinal Muscular Atrophy Treatment in SMA Type 3
Figure 15. Global Spinal Muscular Atrophy Treatment Market: SMA Type 3 (2018-2023) & ($ Millions)
Figure 16. Spinal Muscular Atrophy Treatment in SMA Type 4
Figure 17. Global Spinal Muscular Atrophy Treatment Market: SMA Type 4 (2018-2023) & ($ Millions)
Figure 18. Global Spinal Muscular Atrophy Treatment Market Size Market Share by Application in 2022
Figure 19. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Player in 2022
Figure 20. Global Spinal Muscular Atrophy Treatment Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Spinal Muscular Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 22. APAC Spinal Muscular Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Europe Spinal Muscular Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 25. Americas Spinal Muscular Atrophy Treatment Value Market Share by Country in 2022
Figure 26. United States Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Spinal Muscular Atrophy Treatment Market Size Market Share by Region in 2022
Figure 31. APAC Spinal Muscular Atrophy Treatment Market Size Market Share by Type in 2022
Figure 32. APAC Spinal Muscular Atrophy Treatment Market Size Market Share by Application in 2022
Figure 33. China Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Spinal Muscular Atrophy Treatment Market Size Market Share by Country in 2022
Figure 40. Europe Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2018-2023)
Figure 41. Europe Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2018-2023)
Figure 42. Germany Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Spinal Muscular Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 56. APAC Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 57. Europe Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 59. United States Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Canada Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 63. China Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Japan Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 65. Korea Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 67. India Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 68. Australia Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 69. Germany Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 70. France Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 71. UK Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Italy Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Russia Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 74. Spain Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 77. Israel Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Spinal Muscular Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 80. Global Spinal Muscular Atrophy Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Spinal Muscular Atrophy Treatment Market Size Market Share Forecast by Application (2024-2029)